Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase1, Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for
Metastatic Non Small Cell Lung Cancer
Location: New York NY, Camden NJ, Richmond VA, Natrona Heights PA,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT04614103
Phase2, Recruiting
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for
Colitis, Ulcerative
Location: New York NY, Marlton NJ, Glen Burnie MD, Chevy Chase MD,
Sponsor: Pfizer
Sex: All
Age: 18 - 64
Code: NCT06398626
Recruiting
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: New York NY, Hackensack NJ, Morristown NJ, Bronx NY,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04637763
Phase1, Recruiting
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
for
Single Gene NIPT
Location: New York NY, New Brunswick NJ, New Hyde Park NY,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT06808880
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
for
Peripheral Nerve Injury Upper Limb,
Location: New York NY, Camden NJ, Philadelphia PA, Baltimore MD,
Sponsor: Neuraptive Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT06616025
Phase3, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: New York NY, Hackensack NJ, Nashville TN, St Louis MO,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase1, Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer